AbstractThe aim of this study was to investigate whether supplemental IGF-1Ea transgene expression induces activation of local cardiac and bone marrow stem cell population to mediate mammalian heart repair. In physiologic conditions, cardiac overexpression of the IGF-1Ea propeptide is associated with an enrichment of c-Kit/Sca-1 positive side population cells in the bone marrow and the occurrence of an endothelial-primed CD34 positive side population in the heart. This cellular profile is shown here to correlate with the expression of cytokines involved in stem cell mobilization and vessel formation. This molecular and cellular interplay favored IGF-1Ea-mediated vessel formation in injured hearts. The physiologic and pathologic connection b...
The regenerative capacity of human myocardium is unable to compensate adequately forth significant l...
BACKGROUND: Endogenous cardiac progenitor cells are a promising option for cell-therapy for myocardi...
BackgroundEndogenous cardiac progenitor cells are a promising option for cell-therapy for myocardial...
AbstractThe aim of this study was to investigate whether supplemental IGF-1Ea transgene expression i...
Strategies to limit damage and improve repair after myocardial infarct remain a major therapeutic go...
Strategies to limit damage and improve repair after myocardial infarct remain a major therapeutic go...
Strategies to limit damage and improve repair after myocardial infarct remain a major therapeutic go...
Abstract—We hypothesized that mesenchymal stem cells (MSCs) overexpressing insulin-like growth facto...
AbstractThe mechanism implicated in differentiation of endogenous cardiac stem cells into cardiomyoc...
The goal of this study was to analyse the efficiency of a combinatorial cell/growth factor therapy t...
Cardiac stem cells and early committed cells (CSCs-ECCs) express c-Met and insulin-like growth facto...
Insulin-like growth factor 1 (IGF-1) signaling plays a role in the regulation of heart disease. Whil...
<div><p>Rationale</p><p>Stage specific embryonic antigen 1+ (SSEA1+) cells have been described as th...
Insulin-like growth factor-1 (IGF-1) promotes myocyte proliferation and can reverse cardiac abnormal...
Insulin-like growth factor (IGF-1) is a potent pro-survival cytokine that is not robustly expressed ...
The regenerative capacity of human myocardium is unable to compensate adequately forth significant l...
BACKGROUND: Endogenous cardiac progenitor cells are a promising option for cell-therapy for myocardi...
BackgroundEndogenous cardiac progenitor cells are a promising option for cell-therapy for myocardial...
AbstractThe aim of this study was to investigate whether supplemental IGF-1Ea transgene expression i...
Strategies to limit damage and improve repair after myocardial infarct remain a major therapeutic go...
Strategies to limit damage and improve repair after myocardial infarct remain a major therapeutic go...
Strategies to limit damage and improve repair after myocardial infarct remain a major therapeutic go...
Abstract—We hypothesized that mesenchymal stem cells (MSCs) overexpressing insulin-like growth facto...
AbstractThe mechanism implicated in differentiation of endogenous cardiac stem cells into cardiomyoc...
The goal of this study was to analyse the efficiency of a combinatorial cell/growth factor therapy t...
Cardiac stem cells and early committed cells (CSCs-ECCs) express c-Met and insulin-like growth facto...
Insulin-like growth factor 1 (IGF-1) signaling plays a role in the regulation of heart disease. Whil...
<div><p>Rationale</p><p>Stage specific embryonic antigen 1+ (SSEA1+) cells have been described as th...
Insulin-like growth factor-1 (IGF-1) promotes myocyte proliferation and can reverse cardiac abnormal...
Insulin-like growth factor (IGF-1) is a potent pro-survival cytokine that is not robustly expressed ...
The regenerative capacity of human myocardium is unable to compensate adequately forth significant l...
BACKGROUND: Endogenous cardiac progenitor cells are a promising option for cell-therapy for myocardi...
BackgroundEndogenous cardiac progenitor cells are a promising option for cell-therapy for myocardial...